SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Century Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates

PHILADELPHIA, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune disease, including type 1 diabetes, and other severe diseases where engineered iPSCs ha…

IPSC

Related stories